Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M117Revenue (TTM) $M--Net Margin (%)--Altman Z-Score6.3
Enterprise Value $M107EPS (TTM) $-0.3Operating Margin %--Piotroski F-Score2
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book1.910-y EBITDA Growth Rate %--Quick Ratio10.1Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %-28.3Current Ratio10.1Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-42.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-47.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M106ROIC % (ttm)-63.8Gross Margin Increase y-yN

Gurus Latest Trades with BLRX

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

BLRX is held by these investors:



BLRX: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about BLRX:

    News about BLRX:

    Articles On GuruFocus.com
    BioLineRx Announces Initiation of Phase 3 GENESIS Trial in Stem-Cell Mobilization for Autologous Tra Dec 21 2017 
    BioLineRx Ltd. Hosts Investor Breakfast Meeting in NY Dec 05 2017 
    BioLineRx Reports Overall Survival Results From Long-term Follow-up of Phase 2a Trial in r/r AML Dec 04 2017 
    BioLineRx Announces Partial Results of BL-8040 COMBAT Study Accepted for Presentation at ASCO 2018 G Nov 20 2017 
    BioLineRx Ltd. to Host Investor Breakfast Meeting December 5, 2017 in New York Nov 16 2017 
    BioLineRx to Report Third Quarter 2017 Results on November 21, 2017 Nov 09 2017 
    BioLineRx Announces Oral Presentation at ASH of Data Supporting BL-8040 as Robust Mobilizer of Hemat Nov 02 2017 
    BioLineRx Announces Initiation of Phase 1b/2 Trial for BL-8040 in Gastric Cancer Under Immunotherapy Oct 18 2017 
    BioLineRx Announces Initiation of Phase 1b/2 Trial for BL-8040 in AML Under Immunotherapy Collaborat Sep 26 2017 
    BioLineRx to Present at the 19th Annual Rodman & Renshaw Global Investment Conference in New York Sep 07 2017 
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

    GF Chat

    {{numOfNotice}}
    FEEDBACK